About Univ of Virginia Ophthalmology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
6
Clinical Trials at Univ of Virginia Ophthalmology
During the past decade, Univ of Virginia Ophthalmology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
2014-10-06
2018-01-23
Terminated
975
A Proof-of-Concept Study of Faricimab (RO6867461) in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
2015-08-11
2017-09-26
Completed
273
A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular Edema
2016-04-27
2017-12-14
Completed
229
Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT)
2016-07-21
2018-01-31
Terminated
994
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
2018-10-09
2021-08-27
Completed
951
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema
2020-08-05
2023-08-18
Active, not recruiting
1,479
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Univ of Virginia Ophthalmology
According to Clinical.Site data, the most researched conditions in "Univ of Virginia Ophthalmology" are
"Diabetic Macular Edema" (3 trials), "Geographic Atrophy" (2 trials) and "Choroidal Neovascularization" (1 trials). Many other conditions were trialed in "Univ of Virginia Ophthalmology" in a lesser frequency.
Clinical Trials Intervention Types at Univ of Virginia Ophthalmology
Most popular intervention types in "Univ of Virginia Ophthalmology" are "Drug" (6 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Faricimab" (4 trials), "Sham Procedure" (3 trials), "Lampalizumab" (2 trials), "Ranibizumab" (2 trials) and "Aflibercept" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Univ of Virginia Ophthalmology
The vast majority of trials in "Univ of Virginia Ophthalmology" are
6 trials for "All" genders.
Clinical Trials Status at Univ of Virginia Ophthalmology
Currently, there are NaN active trials in "Univ of Virginia Ophthalmology".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Univ of Virginia Ophthalmology,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Univ of Virginia Ophthalmology, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".